Anthony O. Odibo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anthony O. Odibo has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
George A. Macones
Divisions of Maternal Fetal Medicine and Ultrasound, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri
6 shared publicationsKatherine R. Goetzinger
Department of Obstetrics and Gynecology, Washington University, St. Louis, MO, USA
4 shared publicationsL. Odibo
Division of Maternal Fetal Medicine, Ultrasound and Genetics, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO, USA
4 shared publicationsLinda Odibo
University of South Florida, Tampa, FL
4 shared publicationsAlison G. Cahill
Divisions of Maternal Fetal Medicine and Ultrasound, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri
3 shared publicationsJames P. Crane
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Ultrasound and Genetics, Washington University School of Medicine, St Louis, USA
3 shared publications
Latest Publications
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S157-S158
253: NICHD racial/ethnic standards for fetal growth - do they predict small for gestational age fetuses and short-term neonatal outcomes better than Hadlock's chart?
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S157-S158
253: NICHD racial/ethnic standards for fetal growth - do they predict small for gestational age fetuses and short-term neonatal outcomes better than Hadlock's chart?
- 1 October 2014
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 69 (10) , 575-577
Defining an Abnormal First Stage of Labor Based on Maternal and Neonatal Outcomes
- 1 October 2014
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 69 (10) , 575-577
Defining an Abnormal First Stage of Labor Based on Maternal and Neonatal Outcomes
- 25 April 2014
- Published by Wiley in Prenatal Diagnosis
- Vol. 34 (7) , 635-641
Screening for abnormal placentation and adverse pregnancy outcomes with maternal serum biomarkers in the second trimester
Second trimester biomarkers were initially introduced with the intent of screening for neural tube defects and then subsequently for Down syndrome. It was soon realized that these markers can be indirect evidence of abnormal placentation and, therefore, can be used for screening for adverse pregnancy outcomes. Several new biomarkers have subsequently been described with conflicting findings regarding their efficiency for screening for adverse pregnancy outcomes. Although a biologically feasible mechanism has been proposed for the role of these biomarkers, they still fall short of an ideal screening test to be clinically useful. © 2014 John Wiley & Sons, Ltd.
- 25 April 2014
- Published by Wiley in Prenatal Diagnosis
- Vol. 34 (7) , 635-641
Screening for abnormal placentation and adverse pregnancy outcomes with maternal serum biomarkers in the second trimester
Second trimester biomarkers were initially introduced with the intent of screening for neural tube defects and then subsequently for Down syndrome. It was soon realized that these markers can be indirect evidence of abnormal placentation and, therefore, can be used for screening for adverse pregnancy outcomes. Several new biomarkers have subsequently been described with conflicting findings regarding their efficiency for screening for adverse pregnancy outcomes. Although a biologically feasible mechanism has been proposed for the role of these biomarkers, they still fall short of an ideal screening test to be clinically useful. © 2014 John Wiley & Sons, Ltd.
- 11 February 2014
- Published by Wiley in Prenatal Diagnosis
- Vol. 34 (6) , 511-517
Role of the second‐trimester ‘genetic sonogram’ for Down syndrome screen in the era of first‐trimester screening and noninvasive prenatal testing
Ultrasonography for the screening of Down syndrome was first introduced about 25 years ago. Different combinations of markers detectable at second‐trimester ultrasonography have been proposed under the banner of ‘genetic sonogram’. In recent years, several developments in first‐trimester screening and the recent introduction of noninvasive prenatal testing for aneuploidy screening have had important implications for the prevalence of these conditions in the second‐trimester and the screening performance of a genetic sonogram. Several second‐trimester sonographic markers for Down syndrome have been reported; meta‐analysis has shown that the most powerful predictors are mild ventriculomegaly, increased nuchal fold, hyperechoic bowel, and absent or hypoplastic nasal bone. Whereas use of individual markers should be discouraged and scoring systems of multiple markers are now obsolete, use of combined likelihood ratio and logistic regression analysis formulae provides better accuracy. However, there is significant heterogeneity in results among studies. Despite such limitations, the genetic sonogram will continue to have a place in prenatal screening, particularly in twin and higher‐order multiple pregnancies, in countries with limited access to the most recent genetic screening tests, in cases with borderline results at maternal serum screening tests, and as noninvasive supplementary test for high‐risk women reluctant to undergo invasive diagnostic testing. © 2014 John Wiley & Sons, Ltd.
- 11 February 2014
- Published by Wiley in Prenatal Diagnosis
- Vol. 34 (6) , 511-517
Role of the second‐trimester ‘genetic sonogram’ for Down syndrome screen in the era of first‐trimester screening and noninvasive prenatal testing
Ultrasonography for the screening of Down syndrome was first introduced about 25 years ago. Different combinations of markers detectable at second‐trimester ultrasonography have been proposed under the banner of ‘genetic sonogram’. In recent years, several developments in first‐trimester screening and the recent introduction of noninvasive prenatal testing for aneuploidy screening have had important implications for the prevalence of these conditions in the second‐trimester and the screening performance of a genetic sonogram. Several second‐trimester sonographic markers for Down syndrome have been reported; meta‐analysis has shown that the most powerful predictors are mild ventriculomegaly, increased nuchal fold, hyperechoic bowel, and absent or hypoplastic nasal bone. Whereas use of individual markers should be discouraged and scoring systems of multiple markers are now obsolete, use of combined likelihood ratio and logistic regression analysis formulae provides better accuracy. However, there is significant heterogeneity in results among studies. Despite such limitations, the genetic sonogram will continue to have a place in prenatal screening, particularly in twin and higher‐order multiple pregnancies, in countries with limited access to the most recent genetic screening tests, in cases with borderline results at maternal serum screening tests, and as noninvasive supplementary test for high‐risk women reluctant to undergo invasive diagnostic testing. © 2014 John Wiley & Sons, Ltd.
- 11 December 2013
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 31 (09) , 753-758
Labor Progression in Teenage Women
Objective Compare labor progression in first and second stages in women < 18 years with those ≥18 years. Study Design Retrospective cohort study of consecutive women at term that reached the second stage of labor between 2004 and 2008. The first stage in women < 18 years was compared with women ≥18 years. Average labor curves were constructed and median time spent to progress 1 cm in dilation and total time from 4 to 10 cm was estimated. Time spent pushing and total duration of second stage were compared between groups. Analyses were then stratified by parity. Results There was no significant difference in progress of the first stage of labor between women < 18 years and those ≥18 years. In the second stage, nulliparous teenage women were less likely to have a duration > 60 or 120 minutes. Conclusion Laboring women < 18 years should be managed with the same expectations of labor as women ≥18 years.
- 11 December 2013
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 31 (09) , 753-758
Labor Progression in Teenage Women
Objective Compare labor progression in first and second stages in women < 18 years with those ≥18 years. Study Design Retrospective cohort study of consecutive women at term that reached the second stage of labor between 2004 and 2008. The first stage in women < 18 years was compared with women ≥18 years. Average labor curves were constructed and median time spent to progress 1 cm in dilation and total time from 4 to 10 cm was estimated. Time spent pushing and total duration of second stage were compared between groups. Analyses were then stratified by parity. Results There was no significant difference in progress of the first stage of labor between women < 18 years and those ≥18 years. In the second stage, nulliparous teenage women were less likely to have a duration > 60 or 120 minutes. Conclusion Laboring women < 18 years should be managed with the same expectations of labor as women ≥18 years.
- 28 May 2013
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 41 (6) , 637-642
Customized growth charts for twin gestations to optimize identification of small-for-gestational age fetuses at risk of intrauterine fetal death
Objective Customized growth charts developed for singleton pregnancies have been shown to be more effective than population‐based ones at identifying small‐for‐gestational age (SGA) fetuses at risk for intrauterine fetal death (IUFD). We sought to compare the association between SGA and IUFD in twins using customized growth charts designed for twin gestations compared to those designed for singletons. Methods This was a retrospective cohort study using a database including singleton and twin pregnancies undergoing ultrasound examination between 16 and 20 weeks' gestation. After excluding preterm births < 34 weeks, congenital anomalies and stillbirths, we identified 51 150 singleton births. Coefficients for significant physiological and pathological variables affecting birth weight for singletons were derived using backward stepwise multiple regression. The same process was repeated for twin births (1608 pairs), also adjusting for chorionicity. Customized growth charts for each pregnancy were derived using these two regression models for optimal birth weight at term and a proportionality equation. The association between SGA < 10th percentile, defined using the twin and singleton‐customized charts, and IUFD were compared. Statistical analysis, including calculation of adjusted odds ratios (OR) for IUFD and screening accuracy using each chart, was performed. Results The derived coefficients for optimal birth weight for twins were different from those for singletons, with lower constants and root mean square error (3422 and 288.9, respectively, in twins vs 3543 and 416 in singletons). Among 3786 twin infants, IUFD was seen in 123 (3.2%). The numbers of fetuses identified as SGA were 575 (15.2%) and 504 (13.3%) by the singleton and twin charts, respectively. Fetuses classified as SGA by the twin‐specific customized charts were at a significantly increased risk for IUFD (adjusted OR, 2.3 (95%CI, 1.4–3.5)), whereas those classified as SGA by the singleton‐customized charts were not (adjusted OR, 1.2 (95% CI, 0.7–2.0)). Conclusion Customized charts designed specifically for twins are more effective at identifying twin pregnancies at risk for IUFD than are those derived using singleton birth data. Copyright © 2013 ISUOG. Published by John Wiley & Sons Ltd.
- 28 May 2013
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 41 (6) , 637-642
Customized growth charts for twin gestations to optimize identification of small-for-gestational age fetuses at risk of intrauterine fetal death
Objective Customized growth charts developed for singleton pregnancies have been shown to be more effective than population‐based ones at identifying small‐for‐gestational age (SGA) fetuses at risk for intrauterine fetal death (IUFD). We sought to compare the association between SGA and IUFD in twins using customized growth charts designed for twin gestations compared to those designed for singletons. Methods This was a retrospective cohort study using a database including singleton and twin pregnancies undergoing ultrasound examination between 16 and 20 weeks' gestation. After excluding preterm births < 34 weeks, congenital anomalies and stillbirths, we identified 51 150 singleton births. Coefficients for significant physiological and pathological variables affecting birth weight for singletons were derived using backward stepwise multiple regression. The same process was repeated for twin births (1608 pairs), also adjusting for chorionicity. Customized growth charts for each pregnancy were derived using these two regression models for optimal birth weight at term and a proportionality equation. The association between SGA < 10th percentile, defined using the twin and singleton‐customized charts, and IUFD were compared. Statistical analysis, including calculation of adjusted odds ratios (OR) for IUFD and screening accuracy using each chart, was performed. Results The derived coefficients for optimal birth weight for twins were different from those for singletons, with lower constants and root mean square error (3422 and 288.9, respectively, in twins vs 3543 and 416 in singletons). Among 3786 twin infants, IUFD was seen in 123 (3.2%). The numbers of fetuses identified as SGA were 575 (15.2%) and 504 (13.3%) by the singleton and twin charts, respectively. Fetuses classified as SGA by the twin‐specific customized charts were at a significantly increased risk for IUFD (adjusted OR, 2.3 (95%CI, 1.4–3.5)), whereas those classified as SGA by the singleton‐customized charts were not (adjusted OR, 1.2 (95% CI, 0.7–2.0)). Conclusion Customized charts designed specifically for twins are more effective at identifying twin pregnancies at risk for IUFD than are those derived using singleton birth data. Copyright © 2013 ISUOG. Published by John Wiley & Sons Ltd.
- Open Access
- 4 April 2013
- Published by Springer Nature in Journal of Perinatology
- Vol. 33 (9) , 670-674
First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia
To compare the first-trimester serum concentrations of soluble fms-like tyrosine kinase-1 (sFlt-1), free vascular endothelial growth factor (free-VEGF), placental growth factor (PlGF), and uterine artery pulsatility index (PI) in women who later developed preeclampsia (PE). Prospectively collected maternal serum samples were evaluated for sFlt-1, free VEGF, and PlGF levels in 63 cases who later developed PE compared with 252 unaffected controls. Serum levels of these angiogenic factors were measured using Quantikine immunoassays. Both univariate and multivariate analyses were used to evaluate the association between angiogenic factors and PE. The relationship between the angiogenic factors and mean maternal uterine artery PI was also evaluated. Maternal serum sFlt-1 levels were not significantly different between the cases and controls. Mean free-VEGF levels were significantly higher in women destined to develop PE compared with the controls (P=0.04), and mean PlGF levels were significantly lower in women who later developed PE (P=0.01). There was no significant correlation between maternal mean uterine artery PI and angiogenic factors evaluated. Receiver-operating characteristic curves revealed that none of the factors were clinically useful for prediction in the first trimester of PE. Despite some significant differences in the first-trimester serum levels of angiogenic factors, our models suggest that these factors are not clinically useful for prediction in women who later developed PE.
- 4 April 2013
- Published by Springer Nature in Journal of Perinatology
- Vol. 33 (9) , 670-674
Open AccessFirst-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia
To compare the first-trimester serum concentrations of soluble fms-like tyrosine kinase-1 (sFlt-1), free vascular endothelial growth factor (free-VEGF), placental growth factor (PlGF), and uterine artery pulsatility index (PI) in women who later developed preeclampsia (PE). Prospectively collected maternal serum samples were evaluated for sFlt-1, free VEGF, and PlGF levels in 63 cases who later developed PE compared with 252 unaffected controls. Serum levels of these angiogenic factors were measured using Quantikine immunoassays. Both univariate and multivariate analyses were used to evaluate the association between angiogenic factors and PE. The relationship between the angiogenic factors and mean maternal uterine artery PI was also evaluated. Maternal serum sFlt-1 levels were not significantly different between the cases and controls. Mean free-VEGF levels were significantly higher in women destined to develop PE compared with the controls (P=0.04), and mean PlGF levels were significantly lower in women who later developed PE (P=0.01). There was no significant correlation between maternal mean uterine artery PI and angiogenic factors evaluated. Receiver-operating characteristic curves revealed that none of the factors were clinically useful for prediction in the first trimester of PE. Despite some significant differences in the first-trimester serum levels of angiogenic factors, our models suggest that these factors are not clinically useful for prediction in women who later developed PE.
- 1 April 2013
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 31 (02) , 139-144
Combined Sonographic Testing Index and Prediction of Adverse Outcome in Preterm Fetal Growth Restriction
Objective We sought to test the hypothesis that a combined sonographic scoring system (CSTI) that incorporates features of the biophysical profile (BPP) and multivessel Doppler evaluation improves prediction of adverse outcomes in preterm intrauterine growth restriction. Methods This was a prospective cohort study of growth-restricted fetuses with abnormal umbilical artery (UA) Doppler studies, defined as pulsatility index (PI) > 95th percentile for gestational age or absent/reversed end diastolic flow. Fetuses were followed with weekly BPP and Doppler evaluation of the UA, middle cerebral artery (MCA), and ductus venosus (DV) until the time of delivery. The cerebroplacental Doppler ratio (CPR) was then calculated (MCA PI/UA PI). MCA PI < 5th percentile, MCA peak systolic velocity (PSV) > 1.5 multiples of the median, DV PI > 95th percentile with or without absent/reversed flow, and CPR < 1.08 were considered abnormal. Using logistic regression modeling, a weighted scoring index for the prediction of a composite fetal vulnerability index (FVI), which included 5-minute Apgar score < 3, cord pH < 7.2, seizures, necrotizing enterocolitis, grade 4 intraventricular hemorrhage, periventricular leukomalacia, and neonatal death, was developed. A receiver operating characteristic (ROC) curve was used to identify the best score associated with the FVI. Results Of 66 patients meeting inclusion criteria over a 5-year period, 17 (25.8%) had a positive FVI. Abnormal BPP (< 8), MCA PI, MCA PSV, DV PI, and CPR were observed in 6, 27.3, 13.6, 56.1, and 33.3% of patients, respectively. From the logistic regression model, a CSTI was developed including a score of 1 for abnormal BPP, 3 for MCA PSV, 1 for DV, 6 for CPR, and 3 for oligohydramnios. The ROC curve identified a score of ≥ 7 to be the best predictor of FVI with sensitivity of 35.1% and specificity of 91.8% and a positive likelihood ratio of 4.3 (area under ROC curve 0.73). These test characteristics were better than those for any of the individual component antenatal tests. Conclusion Although this novel scoring system performs modestly in predicting adverse outcomes in FGR, it appears to perform better than any individual antenatal test currently available.
- 1 April 2013
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 31 (02) , 139-144
Combined Sonographic Testing Index and Prediction of Adverse Outcome in Preterm Fetal Growth Restriction
Objective We sought to test the hypothesis that a combined sonographic scoring system (CSTI) that incorporates features of the biophysical profile (BPP) and multivessel Doppler evaluation improves prediction of adverse outcomes in preterm intrauterine growth restriction. Methods This was a prospective cohort study of growth-restricted fetuses with abnormal umbilical artery (UA) Doppler studies, defined as pulsatility index (PI) > 95th percentile for gestational age or absent/reversed end diastolic flow. Fetuses were followed with weekly BPP and Doppler evaluation of the UA, middle cerebral artery (MCA), and ductus venosus (DV) until the time of delivery. The cerebroplacental Doppler ratio (CPR) was then calculated (MCA PI/UA PI). MCA PI < 5th percentile, MCA peak systolic velocity (PSV) > 1.5 multiples of the median, DV PI > 95th percentile with or without absent/reversed flow, and CPR < 1.08 were considered abnormal. Using logistic regression modeling, a weighted scoring index for the prediction of a composite fetal vulnerability index (FVI), which included 5-minute Apgar score < 3, cord pH < 7.2, seizures, necrotizing enterocolitis, grade 4 intraventricular hemorrhage, periventricular leukomalacia, and neonatal death, was developed. A receiver operating characteristic (ROC) curve was used to identify the best score associated with the FVI. Results Of 66 patients meeting inclusion criteria over a 5-year period, 17 (25.8%) had a positive FVI. Abnormal BPP (< 8), MCA PI, MCA PSV, DV PI, and CPR were observed in 6, 27.3, 13.6, 56.1, and 33.3% of patients, respectively. From the logistic regression model, a CSTI was developed including a score of 1 for abnormal BPP, 3 for MCA PSV, 1 for DV, 6 for CPR, and 3 for oligohydramnios. The ROC curve identified a score of ≥ 7 to be the best predictor of FVI with sensitivity of 35.1% and specificity of 91.8% and a positive likelihood ratio of 4.3 (area under ROC curve 0.73). These test characteristics were better than those for any of the individual component antenatal tests. Conclusion Although this novel scoring system performs modestly in predicting adverse outcomes in FGR, it appears to perform better than any individual antenatal test currently available.
- 7 November 2012
- Published by Wiley in Prenatal Diagnosis
- Vol. 33 (1) , 1-5
Summary of the ISPD Preconference Day, June 3, 2012, Miami Beach
- 7 November 2012
- Published by Wiley in Prenatal Diagnosis
- Vol. 33 (1) , 1-5
Summary of the ISPD Preconference Day, June 3, 2012, Miami Beach
- 5 December 2011
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 39 (3) , 288-292
Prediction of intrauterine fetal death in small‐forgestational‐age fetuses: impact of including ultrasound biometry in customized models
Objective: Customized growth charts derived from maternal demographic characteristics alone have been shown to improve the prediction of pregnancy complications compared to population growth curves. We sought to estimate the impact of adding ultrasound biometric parameters to the customized chart for the prediction of intrauterine fetal death (IUFD).Methods: A retrospective cohort study was undertaken using an ultrasound database including singleton pregnancies followed between 16 and 20 weeks' gestation. After exclusion of preterm births, congenital anomalies, multifetal pregnancies and stillbirths (excluded only from derivation samples), we identified 59 016 births, divided into derivation (34 832) and validation (24 184) samples. Coefficients for significant physiological and pathological variables affecting fetal growth were derived using backward stepwise multiple regression (Cust‐chart). The same process was repeated including second‐trimester biometric parameters: biparietal diameter, head circumference, femur length and abdominal circumference in the regression models (Cust‐plus‐USS‐chart). The association between small‐for‐gestational age < 10th centile (SGA) pregnancies, defined using the two customized charts or our population‐based growth chart (Pop‐chart) and IUFD, were compared. Statistical analyses including OR, 95% CI and screening accuracy using each chart were performed.Results: The derived coefficients for fetal growth are comparable to those of previously published series. Of 24 184 pregnancies in the validation sample, IUFD was seen in 169 (0.7%). The pregnancies identified as SGA were: 2482 (10.26%), 2499 (10.33%) and 2634 (10.89%) using the Cust‐chart, Cust‐plus‐USS‐chart and Pop‐chart, respectively. The OR (95% CI) for the association between SGA defined by the three charts and IUFD was: 7.0 (4.5–11), 6.5 (4.2–10.2) and 2.4 (1.6–3.6) according to the Cust‐chart, Cust‐plus‐USS‐chart and Pop‐chart, respectively. Screening efficiency for IUFD using both customized charts was similar, with both demonstrating a higher sensitivity compared with the Pop‐chart.Conclusions: Customized charts are more efficient in identifying pregnancies at risk for IUFD compared with population‐based charts. However, adding second‐trimester ultrasound biometric parameters to the customized model does not improve the prediction of IUFD compared with using maternal characteristics only. Copyright © 2011 ISUOG. Published by John Wiley & Sons, Ltd.
- 5 December 2011
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 39 (3) , 288-292
Prediction of intrauterine fetal death in small‐forgestational‐age fetuses: impact of including ultrasound biometry in customized models
Objective: Customized growth charts derived from maternal demographic characteristics alone have been shown to improve the prediction of pregnancy complications compared to population growth curves. We sought to estimate the impact of adding ultrasound biometric parameters to the customized chart for the prediction of intrauterine fetal death (IUFD).Methods: A retrospective cohort study was undertaken using an ultrasound database including singleton pregnancies followed between 16 and 20 weeks' gestation. After exclusion of preterm births, congenital anomalies, multifetal pregnancies and stillbirths (excluded only from derivation samples), we identified 59 016 births, divided into derivation (34 832) and validation (24 184) samples. Coefficients for significant physiological and pathological variables affecting fetal growth were derived using backward stepwise multiple regression (Cust‐chart). The same process was repeated including second‐trimester biometric parameters: biparietal diameter, head circumference, femur length and abdominal circumference in the regression models (Cust‐plus‐USS‐chart). The association between small‐for‐gestational age < 10th centile (SGA) pregnancies, defined using the two customized charts or our population‐based growth chart (Pop‐chart) and IUFD, were compared. Statistical analyses including OR, 95% CI and screening accuracy using each chart were performed.Results: The derived coefficients for fetal growth are comparable to those of previously published series. Of 24 184 pregnancies in the validation sample, IUFD was seen in 169 (0.7%). The pregnancies identified as SGA were: 2482 (10.26%), 2499 (10.33%) and 2634 (10.89%) using the Cust‐chart, Cust‐plus‐USS‐chart and Pop‐chart, respectively. The OR (95% CI) for the association between SGA defined by the three charts and IUFD was: 7.0 (4.5–11), 6.5 (4.2–10.2) and 2.4 (1.6–3.6) according to the Cust‐chart, Cust‐plus‐USS‐chart and Pop‐chart, respectively. Screening efficiency for IUFD using both customized charts was similar, with both demonstrating a higher sensitivity compared with the Pop‐chart.Conclusions: Customized charts are more efficient in identifying pregnancies at risk for IUFD compared with population‐based charts. However, adding second‐trimester ultrasound biometric parameters to the customized model does not improve the prediction of IUFD compared with using maternal characteristics only. Copyright © 2011 ISUOG. Published by John Wiley & Sons, Ltd.